Therapeutic innovations to find less invasive and more sophisticated methods to accelerate the process of diagnosing and treating lung cancer have increased the life expectancy and quality of life of patients. The technology It can be a powerful tool for improving care and effectiveness of diagnosis and treatment, as well as clinical outcomes, and reducing the overall cost of care.
Global public health problem
Data from the Global Cancer Observatory estimate that during 2020 this type of tumor had an incidence of more than two million cases in the world. While they showed up around 1.8 million deaths from this cause. While at the national level, 7,811 new cases and 6,733 deaths were registered in Mexico.
Diagnosis earlier in the development of lung cancer is associated with better outcomes and better chances of survival. Currently, more than 60% of patients are diagnosed at a late stage, reducing the possibility of surgical cure.
In addition to early diagnosis, prompt treatment is essential to ensure better outcomes and quality of life for patients with lung cancer.
One of the newest professional equipment in the world
In this context, the world leader in healthcare technology Philips offers interventional radiology and advanced bronchoscopy the Azurion Lung Suite. It is an innovative 3D imaging and navigation platform that enables healthcare practitioners and institutions to accelerate lung cancer diagnosis and treatment, all in one. With this, it allows at the same time the improvement of the clinical results and the reduction of the cost of the care.
With the goal of providing the best care for patients with lung cancer, the company provides technology to have a shorter path to a definitive diagnosis and reduce the painful experience of recovery that involves open surgery. The platform is designed for bronchoscopy procedures, allowing clinicians to perform minimally invasive endobronchial biopsies and lesion removal during the same procedure. While offering patients same day diagnosis and treatment.
Minimally invasive image-guided procedures continue to expand into new treatment areas that have the potential to significantly improve patient outcomes. Azurion enables healthcare institutions to have a hybrid operating room and tailor patient care plans in a single day, rather than scheduling multiple follow-up appointments. This approach, in addition to avoiding the worst prognosis associated with late treatment, is a profitable model for health institutions.
Azurion Lung Suite features XperGuide image needle navigation technology and CBCT (Cone Beam Computed Tomography) which increases precision and allows targeting smaller lesions (